{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:18:16Z","timestamp":1792451896084,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"21","license":[{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","award":["The Neuropsychiatry Drug Discovery Consortium, Res"],"award-info":[{"award-number":["The Neuropsychiatry Drug Discovery Consortium, Res"]}],"id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI \/ JP26670122"],"award-info":[{"award-number":["KAKENHI \/ JP26670122"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["Strategic Research Program for Brain Sciences"],"award-info":[{"award-number":["Strategic Research Program for Brain Sciences"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["Research Grant"],"award-info":[{"award-number":["Research Grant"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00213-017-4703-9","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T06:39:17Z","timestamp":1502347157000},"page":"3217-3228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice"],"prefix":"10.1007","volume":"234","author":[{"given":"Yuta","family":"Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuki","family":"Taruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"4703_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neuint.2007.07.012","volume":"52","author":"YU Adachi","year":"2008","unstructured":"Adachi YU, Yamada S, Satomoto M, Higuchi H, Watanabe K, Kazama T, Mimuro S, Sato S (2008) Isoflurane anesthesia inhibits clozapine- and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study. Neurochem Int 52:384\u2013391. doi:\n                    10.1016\/j.neuint.2007.07.012","journal-title":"Neurochem Int"},{"key":"4703_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.npp.1300567","volume":"30","author":"Y Ago","year":"2005","unstructured":"Ago Y, Nakamura S, Baba A, Matsuda T (2005) Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30:43\u201351. doi:\n                    10.1038\/sj.npp.1300567","journal-title":"Neuropsychopharmacology"},{"key":"4703_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/aur.1395","volume":"7","author":"DA Amodeo","year":"2014","unstructured":"Amodeo DA, Jones JH, Sweeney JA, Ragozzino ME (2014) Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf\/J mice. Autism Res 7:555\u2013567. doi:\n                    10.1002\/aur.1395","journal-title":"Autism Res"},{"key":"4703_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00213-007-0698-y","volume":"191","author":"A Bortolozzi","year":"2007","unstructured":"Bortolozzi A, D\u00edaz-Mataix L, Toth M, Celada P, Artigas F (2007) In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Psychopharmacology 191:745\u2013758. doi:\n                    10.1007\/s00213-007-0698-y","journal-title":"Psychopharmacology"},{"key":"4703_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1017\/S146114571000009X","volume":"13","author":"A Bortolozzi","year":"2010","unstructured":"Bortolozzi A, Masana M, D\u00edaz-Mataix L, Cort\u00e9s R, Scorza MC, Gingrich JA, Toth M, Artigas F (2010) Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors. Int J Neuropsychopharmacol 13:1299\u20131314. doi:\n                    10.1017\/S146114571000009X","journal-title":"Int J Neuropsychopharmacol"},{"key":"4703_CR6","doi-asserted-by":"crossref","unstructured":"Broadbent NJ, Gaskin S, Squire LR, Clark RE (2010) Object recognition memory and the rodent hippocampus. Learn Mem 17(1):5\u201311","DOI":"10.1101\/lm.1650110"},{"key":"4703_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1124\/jpet.102.033175","volume":"302","author":"KD Burris","year":"2002","unstructured":"Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381\u2013389. doi:\n                    10.1124\/jpet.102.033175","journal-title":"J Pharmacol Exp Ther"},{"key":"4703_CR8","doi-asserted-by":"publisher","first-page":"712758","DOI":"10.1155\/2013\/712758","volume":"2013","author":"T Chomiak","year":"2013","unstructured":"Chomiak T, Turner N, Hu B (2013) What we have learned about autism spectrum disorder from valproic acid. Pathol Res Int 2013:712758. doi:\n                    10.1155\/2013\/712758","journal-title":"Pathol Res Int"},{"key":"4703_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1601-183X.2010.00656.x","volume":"10","author":"LM DeVito","year":"2011","unstructured":"DeVito LM, Balu DT, Kanter BR, Lykken C, Basu AC, Coyle JT, Eichenbaum H (2011) Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav 10:210\u2013222. doi:\n                    10.1111\/j.1601-183X.2010.00656.x","journal-title":"Genes Brain Behav"},{"key":"4703_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.0953-816X.2004.03154.x","volume":"19","author":"R Diaz Heijtz","year":"2004","unstructured":"Diaz Heijtz R, Scott L, Forssberg H (2004) Alteration of dopamine D1 receptor-mediated motor inhibition and stimulation during development in rats is associated with distinct patterns of c-fos mRNA expression in the frontal-striatal circuitry. Eur J Neurosci 19:945\u2013956. doi:\n                    10.1111\/j.0953-816X.2004.03154.x","journal-title":"Eur J Neurosci"},{"key":"4703_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbr.2016.05.009","volume":"310","author":"MR Farrell","year":"2016","unstructured":"Farrell MR, Holland FH, Shansky RM, Brenhouse HC (2016) Sex-specific effects of early life stress on social interaction and prefrontal cortex dendritic morphology in young rats. Behav Brain Res 310:119\u2013125. doi:\n                    10.1016\/j.bbr.2016.05.009","journal-title":"Behav Brain Res"},{"key":"4703_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbr.2007.03.011","volume":"18","author":"N Ferdman","year":"2007","unstructured":"Ferdman N, Murmu RP, Bock J, Braun K, Leshem M (2007) Weaning age, social isolation, and gender, interact to determine adult explorative and social behavior, and dendritic and spine morphology in prefrontal cortex of rats. Behav Brain Res 18:174\u2013182. doi:\n                    10.1016\/j.bbr.2007.03.011","journal-title":"Behav Brain Res"},{"key":"4703_CR13","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1016\/S0024-3205(00)00872-9","volume":"67","author":"M Fujimura","year":"2000","unstructured":"Fujimura M, Hashimoto K, Yamagami K (2000) The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone. Life Sci 67:2865\u20132872. doi:\n                    10.1016\/S0024-3205(00)00872-9","journal-title":"Life Sci"},{"key":"4703_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.2010.07104.x","volume":"116","author":"GG Gould","year":"2011","unstructured":"Gould GG, Hensler JG, Burke TF, Benno RH, Onaivi ES, Daws LC (2011) Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf\/J mouse social behavior. J Neurochem 116:291\u2013303. doi:\n                    10.1111\/j.1471-4159.2010.07104.x","journal-title":"J Neurochem"},{"key":"4703_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1254\/jphs.12025SC","volume":"118","author":"Y Hara","year":"2012","unstructured":"Hara Y, Maeda Y, Kataoka S, Ago Y, Takuma K, Matsuda T (2012) Effect of prenatal valproic acid exposure on cortical morphology in female mice. J Pharmacol Sci 118:543\u2013546. doi:\n                    10.1254\/jphs.12025SC","journal-title":"J Pharmacol Sci"},{"key":"4703_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbr.2015.04.022","volume":"289","author":"Y Hara","year":"2015","unstructured":"Hara Y, Takuma K, Takano E, Katashiba K, Taruta A, Higashino K, Hashimoto H, Ago Y, Matsuda T (2015) Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model. Behav Brain Res 289:39\u201347. doi:\n                    10.1016\/j.bbr.2015.04.022","journal-title":"Behav Brain Res"},{"key":"4703_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/aur.1596","volume":"9","author":"Y Hara","year":"2016","unstructured":"Hara Y, Ago Y, Taruta A, Katashiba K, Hasebe S, Takano E, Onaka Y, Hashimoto H, Matsuda T, Takuma K (2016) Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism. Autism Res 9:926\u2013939. doi:\n                    10.1002\/aur.1596","journal-title":"Autism Res"},{"key":"4703_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jaac.2012.04.011","volume":"51","author":"M Harfterkamp","year":"2012","unstructured":"Harfterkamp M, van de Loo-Neus G, Minderaa RB, van der Gaag RJ, Escobar R, Schacht A, Pamulapati S, Buitelaar JK, Hoekstra PJ (2012) A randomized double-blind study of atomoxetine versus placebo for attention-deficit\/hyperactivity disorder symptoms in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 51:733\u2013741. doi:\n                    10.1016\/j.jaac.2012.04.011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4703_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/BF02245607","volume":"124","author":"P Hertel","year":"1996","unstructured":"Hertel P, Nomikos GG, Iurlo M, Svensson TH (1996) Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology 124:74\u201386. doi:\n                    10.1007\/BF02245607","journal-title":"Psychopharmacology"},{"key":"4703_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pnpbp.2015.12.002","volume":"66","author":"GB Huang","year":"2016","unstructured":"Huang GB, Zhao T, Gao XL, Zhang HX, Xu YM, Li H, Lv LX (2016) Effect of chronic social defeat stress on behaviors and dopamine receptor in adult mice. Prog Neuro-Psychopharmacol Biol Psychiatry 66:73\u201379. doi:\n                    10.1016\/j.pnpbp.2015.12.002","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"4703_CR21","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","volume":"76","author":"J Ichikawa","year":"2001","unstructured":"Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY (2001) 5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521\u20131531. doi:\n                    10.1046\/j.1471-4159.2001.00154.x","journal-title":"J Neurochem"},{"key":"4703_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S1461145711001714","volume":"16","author":"S Kataoka","year":"2013","unstructured":"Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T (2013) Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharmacol 16:91\u2013103. doi:\n                    10.1017\/S1461145711001714","journal-title":"Int J Neuropsychopharmacol"},{"key":"4703_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","volume":"201","author":"KC Kim","year":"2011","unstructured":"Kim KC, Kim P, Go HS, Choi CS, Yang SI, Cheong JH, ShinCY KKH (2011) The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett 201:137\u2013142. doi:\n                    10.1016\/j.toxlet.2010.12.018","journal-title":"Toxicol Lett"},{"key":"4703_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1471-4159.2010.06750.x","volume":"114","author":"K Koda","year":"2010","unstructured":"Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T (2010) Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 114:259\u2013270. doi:\n                    10.1111\/j.1471-4159.2010.06750.x","journal-title":"J Neurochem"},{"key":"4703_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mcn.2012.03.005","volume":"50","author":"VA Kulkarni","year":"2012","unstructured":"Kulkarni VA, Firestein BL (2012) The dendritic tree and brain disorders. Mol Cell Neurosci 50:10\u201320. doi:\n                    10.1016\/j.mcn.2012.03.005","journal-title":"Mol Cell Neurosci"},{"key":"4703_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s002130050551","volume":"136","author":"XM Li","year":"1998","unstructured":"Li XM, Perry KW, Wong DT, Bymaster FP (1998) Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 136:153\u2013161. doi:\n                    10.1007\/s002130050551","journal-title":"Psychopharmacology"},{"key":"4703_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2004.04.028","volume":"493","author":"Z Li","year":"2004","unstructured":"Li Z, Ichikawa J, Dai J, Meltzer HY (2004) Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol 493:75\u201383. doi:\n                    10.1016\/j.ejphar.2004.04.028","journal-title":"Eur J Pharmacol"},{"key":"4703_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainres.2006.11.060","volume":"1134","author":"Z Li","year":"2007","unstructured":"Li Z, Huang M, Prus AJ, Dai J, Meltzer HY (2007) 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus. Brain Res 1134:70\u201378. doi:\n                    10.1016\/j.brainres.2006.11.060","journal-title":"Brain Res"},{"key":"4703_CR29","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","volume":"48","author":"RN Marcus","year":"2009","unstructured":"Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG (2009) A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48:1110\u20131119. doi:\n                    10.1097\/CHI.0b013e3181b76658","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"4703_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"JT McCracken","year":"2002","unstructured":"McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D, Research Units on Pediatric Psychopharmacology Autism Network (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med 347:314\u2013321. doi:\n                    10.1056\/NEJMoa013171","journal-title":"N Engl J Med"},{"key":"4703_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1101\/lm.461407","volume":"14","author":"T Nagai","year":"2007","unstructured":"Nagai T, Takuma K, Kamei H, Ito Y, Nakamichi N, Ibi D, Nakanishi Y, Murai M, Mizoguchi H, Nabeshima T, Yamada K (2007) Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1\/2 in the prefrontal cortex. Learn Mem 14:117\u2013125. doi:\n                    10.1101\/lm.461407","journal-title":"Learn Mem"},{"key":"4703_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejphar.2012.04.046","volume":"686","author":"JJ O'Connor","year":"2012","unstructured":"O'Connor JJ, Lowry JP (2012) A comparison of the effects of the dopamine partial agonists aripiprazole and (\u2212)-3-PPP with quinpirole on stimulated dopamine release in the rat striatum: studies using fast cyclic voltammetry in vitro. Eur J Pharmacol 686:60\u201365. doi:\n                    10.1016\/j.ejphar.2012.04.046","journal-title":"Eur J Pharmacol"},{"key":"4703_CR33","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L, Marcus RN, Corey-Lisle P, Manos G, McQuade RD, Carson WH, Findling RL (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124:1533\u20131540. doi:\n                    10.1542\/peds.2008-3782","journal-title":"Pediatrics"},{"key":"4703_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","volume":"147","author":"O Pe\u00f1agarikano","year":"2011","unstructured":"Pe\u00f1agarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, Sonnenblick LI, Gruver R, Almajano J, Bragin A, Golshani P, Trachtenberg JT, Peles E, Geschwind DH (2011) Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147:235\u2013246. doi:\n                    10.1016\/j.cell.2011.08.040","journal-title":"Cell"},{"key":"4703_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nn.2741","volume":"14","author":"P Penzes","year":"2011","unstructured":"Penzes P, Cahill ME, Jones KA, Van Leeuwen JE, Woolfrey KM (2011) Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci 14:285\u2013293. doi:\n                    10.1038\/nn.2741","journal-title":"Nat Neurosci"},{"key":"4703_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2202-15-30","volume":"15","author":"A Pereira","year":"2014","unstructured":"Pereira A, Zhang B, Malcolm P, Sugiharto-Winarno A, Sundram S (2014) Quetiapine and aripiprazole signal differently to ERK, p90RSK and c-Fos in mouse frontal cortex and striatum: role of the EGF receptor. BMC Neurosci 15:30. doi:\n                    10.1186\/1471-2202-15-30","journal-title":"BMC Neurosci"},{"key":"4703_CR37","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2006.09.028","volume":"61","author":"DJ Posey","year":"2007","unstructured":"Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, Young C, Wheeler C, McDougle CJ (2007) Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry 61:538\u2013544. doi:\n                    10.1016\/j.biopsych.2006.09.028","journal-title":"Biol Psychiatry"},{"key":"4703_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nlm.2013.07.012","volume":"106","author":"JI Rossato","year":"2013","unstructured":"Rossato JI, Radiske A, Kohler CA, Gonzalez C, Bevilaqua LR, Medina JH, Cammarota M (2013) Consolidation of object recognition memory requires simultaneous activation of dopamine D1\/D5 receptors in the amygdala and medial prefrontal cortex but not in the hippocampus. Neurobiol Learn Mem 106:66\u201370. doi:\n                    10.1016\/j.nlm.2013.07.012","journal-title":"Neurobiol Learn Mem"},{"key":"4703_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","volume":"36","author":"FI Roullet","year":"2013","unstructured":"Roullet FI, Lai JK, Foster JA (2013) In utero exposure to valproic acid and autism\u2014a current review of clinical and animal studies. Neurotoxicol Teratol 36:47\u201356. doi:\n                    10.1016\/j.ntt.2013.01.004","journal-title":"Neurotoxicol Teratol"},{"key":"4703_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.npp.1300518","volume":"30","author":"T Schneider","year":"2005","unstructured":"Schneider T, Przew\u0142ocki R (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30:80\u201389. doi:\n                    10.1038\/sj.npp.1300518","journal-title":"Neuropsychopharmacology"},{"key":"4703_CR41","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","volume":"114","author":"S Shea","year":"2004","unstructured":"Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114:e634\u2013e641. doi:\n                    10.1542\/peds.2003-0264-F","journal-title":"Pediatrics"},{"key":"4703_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pbb.2014.08.013","volume":"126","author":"K Takuma","year":"2014","unstructured":"Takuma K, Hara Y, Kataoka S, Kawanai T, Maeda Y, Watanabe R, Takano E, Hayata-Takano A, Hashimoto H, Ago Y, Matsuda T (2014) Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism. Pharmacol Biochem Behav 126:43\u201349. doi:\n                    10.1016\/j.pbb.2014.08.013","journal-title":"Pharmacol Biochem Behav"},{"key":"4703_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuropharm.2015.12.025","volume":"105","author":"BL Teng","year":"2016","unstructured":"Teng BL, Nikolova VD, Riddick NV, Agster KL, Crowley JJ, Baker LK, Koller BH, Pedersen CA, Jarstfer MB, Moy SS (2016) Reversal of social deficits by subchronic oxytocin in two autism mouse models. Neuropharmacology 105:61\u201371. doi:\n                    10.1016\/j.neuropharm.2015.12.025","journal-title":"Neuropharmacology"},{"key":"4703_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","volume":"36","author":"GC Wagner","year":"2006","unstructured":"Wagner GC, Reuhl KR, Cheh M, McRae P, Halladay AK (2006) A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 36:779\u2013793. doi:\n                    10.1007\/s10803-006-0117-y","journal-title":"J Autism Dev Disord"},{"key":"4703_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1471-4159.1990.tb13299.x","volume":"54","author":"DE Walters","year":"1990","unstructured":"Walters DE, Chapman CD, Howard SG (1990) Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis. J Neurochem 54:181\u2013186. doi:\n                    10.1111\/j.1471-4159.1990.tb13299.x","journal-title":"J Neurochem"},{"key":"4703_CR46","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.npp.1301521","volume":"33","author":"HD Wang","year":"2008","unstructured":"Wang HD, Deutch AY (2008) Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. Neuropsychopharmacology 33:1276\u20131286. doi:\n                    10.1038\/sj.npp.1301521","journal-title":"Neuropsychopharmacology"},{"key":"4703_CR47","doi-asserted-by":"publisher","first-page":"10298","DOI":"10.1074\/jbc.M112.415141","volume":"288","author":"D Wang","year":"2013","unstructured":"Wang D, Fu Q, Zhou Y, Xu B, Shi Q, Igwe B, Matt L, Hell JW, Wisely EV, Oddo S, Xiang YK (2013) \u03b22 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models. J Biol Chem 288:10298\u201310307. doi:\n                    10.1074\/jbc.M112.415141","journal-title":"J Biol Chem"},{"key":"4703_CR48","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/npp.2011.254","volume":"37","author":"DJ Watson","year":"2012","unstructured":"Watson DJ, Loiseau F, Ingallinesi M, Millan MJ, Marsden CA, Fone KC (2012) Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. Neuropsychopharmacology 37:770\u2013786. doi:\n                    10.1038\/npp.2011.254","journal-title":"Neuropsychopharmacology"},{"key":"4703_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2015.02.031","volume":"286","author":"Y Xu","year":"2015","unstructured":"Xu Y, Cao W, Zhou M, Li C, Luo Y, Wang H, Zhao R, Jiang S, Yang J, Liu Y, Wang X, Li X, Xiong W, Ma J, Peng S, Zeng Z, Li X, Tan M, Li G (2015) Inactivation of BRD7 results in impaired cognitive behavior and reduced synaptic plasticity of the medial prefrontal cortex. Behav Brain Res 286:1\u201310. doi:\n                    10.1016\/j.bbr.2015.02.031","journal-title":"Behav Brain Res"},{"key":"4703_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2006.11.011","volume":"1131","author":"H Yamada","year":"2007","unstructured":"Yamada H, Kuroki T, Nakahara T, Hashimoto K, Tsutsumi T, Hirano M, Maeda H (2007) The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens. Brain Res 1131:88\u201396. doi:\n                    10.1016\/j.brainres.2006.11.011","journal-title":"Brain Res"},{"key":"4703_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2014.12.010","volume":"586","author":"DH Yoon","year":"2015","unstructured":"Yoon DH, Yoon S, Kim D, Kim H, Baik JH (2015) Regulation of dopamine D2 receptor-mediated extracellular signal-regulated kinase signaling and spine formation by GABAA receptors in hippocampal neurons. Neurosci Lett 586:24\u201330. doi:\n                    10.1016\/j.neulet.2014.12.010","journal-title":"Neurosci Lett"},{"key":"4703_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neulet.2005.06.035","volume":"387","author":"A Zocchi","year":"2005","unstructured":"Zocchi A, Fabbri D, Heidbreder CA (2005) Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex. Neurosci Lett 387:157\u2013161. doi:\n                    10.1016\/j.neulet.2005.06.035","journal-title":"Neurosci Lett"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4703-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4703-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4703-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T09:07:58Z","timestamp":1589620078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4703-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":52,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4703"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4703-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]},"assertion":[{"value":"15 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}